nifedipine has been researched along with betamethasone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Yokoyama, M | 1 |
| Bennert, H; Stubblefield, PG; Trice, L | 1 |
| de Heus, R; Derks, JB; Mulder, EJ; Visser, GH | 1 |
| Baykal, C; Kaya, S; Takal, MK; Yakupoğlu, U | 1 |
| de Jong, MH; Derksen, MT; Koster, MI; Van Gool, AR | 1 |
| Cool, DR; Grunwald, WC; Haidar, ZA; Mckenna, DS; Sammohi, S; Sibai, BM; Sonek, JD | 1 |
| Abdelghani, GM; Elghadban, HM; Mohamed, EA; Salem, AE | 1 |
| Coates, S; Gotteland, JP; Lorch, U; Marchand, L; Pohl, O; Täubel, J | 1 |
| Emeruwa, UN; Krenitsky, NM; Sheen, JJ | 1 |
1 review(s) available for nifedipine and betamethasone
| Article | Year |
|---|---|
Advances in Management for Preterm Fetuses at Risk of Delivery.
Topics: Anti-Bacterial Agents; Anticonvulsants; Betamethasone; Dexamethasone; Female; Fetal Membranes, Premature Rupture; Fetal Organ Maturity; Fetal Viability; Glucocorticoids; Humans; Indomethacin; Magnesium Sulfate; Neonatal Sepsis; Neuroprotective Agents; Nifedipine; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae; Tocolysis; Tocolytic Agents | 2020 |
3 trial(s) available for nifedipine and betamethasone
| Article | Year |
|---|---|
The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow.
Topics: Adult; Algorithms; Betamethasone; Drug Combinations; Female; Fetal Blood; Fetal Movement; Heart Rate, Fetal; Humans; Infant, Newborn; Nifedipine; Placental Circulation; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolytic Agents; Vasotocin | 2009 |
Potential combination topical therapy of anal fissure: development, evaluation, and clinical study†.
Topics: Administration, Topical; Adult; Aged; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Drug Combinations; Drug Compounding; Drug Therapy, Combination; Excipients; Female; Fissure in Ano; Gels; Humans; Lidocaine; Male; Middle Aged; Nifedipine; Prospective Studies; Vasodilator Agents; Young Adult | 2018 |
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.
Topics: Adolescent; Adult; Area Under Curve; Betamethasone; Cross-Over Studies; Drug Interactions; Esters; Female; Humans; Magnesium Sulfate; Middle Aged; Nifedipine; Receptors, Prostaglandin; Sulfones; Thiazolidines; Tocolytic Agents; Vasotocin; Young Adult | 2019 |
19 other study(ies) available for nifedipine and betamethasone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The effect of pharmacological pretreatment on the long-term globally ischemic heart; lysosome, cyclic nucleotide and myocardial injury].
Topics: Animals; Aprotinin; Betamethasone; Coronary Disease; Creatine Kinase; Cyclic AMP; Cyclic GMP; Dogs; Heart Arrest, Induced; Isoenzymes; Lysosomes; Myocardium; Nifedipine; Perfusion; Ubiquinone | 1987 |
Massive vulvar edema complicating tocolysis in a patient with twins. A case report.
Topics: Adult; Betamethasone; Drug Therapy, Combination; Edema; Female; Glucocorticoids; Humans; Infant, Newborn; Leukocyte Count; Magnesium Sulfate; Male; Nifedipine; Obstetric Labor, Premature; Pregnancy; Terbutaline; Tocolytic Agents; Twins; Vulvar Diseases | 1996 |
Successful management of a high-risk pregnancy with polyhydramnios, IUGR and recurrent pregnancy loss in a chronic renal failure patient: a case report.
Topics: Abortion, Habitual; Adult; Amniotic Fluid; Betamethasone; Birth Weight; Female; Fetal Growth Retardation; Humans; Indomethacin; Infant, Newborn; Kidney Failure, Chronic; Male; Nifedipine; Pregnancy; Pregnancy Complications; Renal Dialysis | 2011 |
['Steroid psychosis' during treatment for premature labour].
Topics: Adult; Antipsychotic Agents; Betamethasone; Female; Glucocorticoids; Haloperidol; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Psychoses, Substance-Induced; Tocolytic Agents | 2011 |
Effect of Tocolytics on Surfactant Secretion When Administered with Betamethasone: An in Vitro Study.
Topics: Betamethasone; Cell Line; Glucocorticoids; Humans; Indomethacin; Lecithins; Lung; Magnesium Sulfate; Nifedipine; Pulmonary Surfactant-Associated Protein B; Sphingomyelins; Tocolytic Agents | 2015 |